Skip to content
healthcare.dev

darunavir

NDC 76282-738, darunavir 800 mg, tablet, from EXELAN PHARMACEUTICALS INC..

Product NDC
76282-738
Status
Listed
Labeler
EXELAN PHARMACEUTICALS INC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206288
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76282-738 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DARUNAVIR HYDRATE800 mg/1

Pharmacologic classes

Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; HIV Protease Inhibitors [MoA]; Protease Inhibitor [EPC]

Package NDCNDC-11Package
76282-738-307628207383030 TABLET in 1 BOTTLE (76282-738-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ed977166-7ac0-4a8c-a10c-4b19a69403c0
  • NADAC price for package 76282073830

    GET /v1/drugs/nadac/76282073830

Use it

Look up 76282-738 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76282-738 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76282-738. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.